Editing Autosomal dominant polycystic kidney disease (section)

===Dialysis===
Two modalities of [[Kidney dialysis|dialysis]] can be used in the treatment of ADPKD patients: [[peritoneal dialysis]] and [[hemodialysis]].<ref name="TP-150518-E14">{{cite journal | vauthors = Courivaud C, Roubiou C, Delabrousse E, Bresson-Vautrin C, Chalopin JM, Ducloux D | title = Polycystic kidney size and outcomes on peritoneal dialysis: comparison with haemodialysis | journal = Clinical Kidney Journal | volume = 7 | issue = 2 | pages = 138–143 | date = April 2014 | pmid = 25852862 | pmc = 4377775 | doi = 10.1093/ckj/sft171 }}</ref> Epidemiological data shows that ADPKD affects 5–13.4% of patients undergoing hemodialysis in Europe and in the United States,<ref name="TP-150518-E15">{{cite journal | vauthors = Nunes AC, Milani V, Porsch DB, Rossato LB, Mattos CB, Roisenberg I, Barros EJ | title = Frequency and clinical profile of patients with polycystic kidney disease in southern Brazil | journal = Renal Failure | volume = 30 | issue = 2 | pages = 169–173 | year = 2008 | pmid = 18300116 | doi = 10.1080/08860220701810265 | doi-access = free }}</ref><ref name="TP-150518-E16">{{cite journal | vauthors = Bleyer AJ, Hart TC | title = Polycystic kidney disease | journal = The New England Journal of Medicine | volume = 350 | issue = 25 | pages = 2622; author reply 2622 | date = June 2004 | pmid = 15201424 | doi = 10.1056/NEJM200406173502519 }}</ref><ref name="TP-150518-E17">{{cite journal | vauthors = Corradi V, Gastaldon F, Virzì GM, de Cal M, Soni S, Chionh C, Cruz DN, Clementi M, Ronco C | display-authors = 6 | title = Clinical pattern of adult polycystic kidney disease in a northeastern region of Italy | journal = Clinical Nephrology | volume = 72 | issue = 4 | pages = 259–267 | date = October 2009 | pmid = 19825331 | doi = 10.5414/CNP72259 }}</ref> and about 3% in Japan.<ref name="TP-150518-E18"/> Peritoneal dialysis has usually been contra-indicated in ADPKD patients with large kidney and liver volumes, due to expected physical difficulties in the procedure and possible complications;<ref name="TP-150518-E14" /><ref name="TP-150518-E19">{{cite journal | vauthors = Hamanoue S, Hoshino J, Suwabe T, Marui Y, Ueno T, Kikuchi K, Hazue R, Mise K, Kawada M, Imafuku A, Hayami N, Sumida K, Hiramatsu R, Hasegawa E, Sawa N, Takaichi K, Ubara Y | display-authors = 6 | title = Peritoneal Dialysis is Limited by Kidney and Liver Volume in Autosomal Dominant Polycystic Kidney Disease | journal = Therapeutic Apheresis and Dialysis | volume = 19 | issue = 3 | pages = 207–211 | date = June 2015 | pmid = 25612237 | doi = 10.1111/1744-9987.12272 | s2cid = 27836789 }}</ref> however, no difference is seen in long-term morbidity between hemodialysis and peritoneal dialysis in ADPKD.<ref name="TP-150518-E14" />